MATE1 expression in the cochlea and its potential involvement in cisplatin cellular uptake and ototoxicity. (1st March 2023)

• Record Type: Journal Article
• Authors: Waissbluth, Sofia; Martínez, Agustín D.; Figueroa-Cares, Cindel; Sánchez, Helmuth A.; Maass, Juan C.
• Is Part Of: Acta oto-laryngologica. Volume 143:Number 3(2023)
• Page Start: 242
• Page End: 249
• Publication Date: 2023-03-01
• Subjects: OCT2 -- MATE -- MATE1 -- cisplatin -- platinum -- ototoxicity -- transporters -- organic cation transporter -- pillar cell -- outer hair cell; Otolaryngology -- Periodicals; Ear -- Diseases -- Periodicals; Throat -- Diseases -- Periodicals; Otolaryngology -- Electronic Resources; Otorhinolaryngologic Diseases; 617.8
• DOI: 10.1080/00016489.2023.2184864
• Languages: English
• ISSNs: 0001-6489

Abstract

Abstract: Background: Cisplatin appears to enter the cochlear cells through the organic cation transporter 2 (OCT2). There is recent evidence that multidrug and toxin extrusion protein 1 (MATE1) is involved in cisplatin-induced nephrotoxicity. Its presence and role in the ear are unknown. Aims/Objectives: Evaluate the presence and localization of MATE1, and determine the localization of OCT2, in the cochlea. Evaluate cisplatin uptake with regard to MATE1 and OCT2 expression. Material and Methods: Murine cochlear explants and paraffin-embedded cochleae were evaluated with immunohistochemistry for OCT2 and MATE1. Explant cultures were also treated with Texas Red cisplatin to determine their cellular uptake. Results: MATE1 is present in the cochlea. Most intense labeling of MATE1 and OCT2 was seen in the outer hair cells (OHCs) and pillar cells, respectively. Both transporters were observed in the spiral ganglion neurons and stria vascularis. Expression levels of OCT2 and MATE1 decreased following cisplatin exposure. Texas Red cisplatin staining was strong in OHCs and pillar cells. Conclusions and Significance: To the best of our knowledge, this is the first study demonstrating the presence and localization of MATE1 in the cochlea. OCT2 labeling was seen in pillar cells. Consistently, OHCs and pillar cells uptake Texas Red cisplatin.